Interestingly, the combination of IFN-γ and anti-HER2 antibodies (which exert anti-tumor activity via blocking growth factor signaling as well as through other mechanisms) has shown anti-tumor activity in mouse models [44]. The gene discussed is ERBB2; the disease is neoplasm.